Back to Trades
Kerr Douglas
InsiderCIK 0001814189
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 8
- Buy transactions
- 0
- Sell transactions
- 8
- Companies
- 1
- Active
- 2025–2026
Kerr Douglas has filed 8 SEC reports (2025–2026), all concentrated in Dyne Therapeutics, Inc. (DYN), totaling $3.0M in disclosed volume. Weighing $0 bought versus $278.5K sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
8 loaded
| Sep 8 | DYN Dyne Therapeutics, Inc. | Kerr Douglas | Insider | Sell | $115.5K |
| Aug 17 | DYN Dyne Therapeutics, Inc. | Kerr Douglas | Insider | Sell | $40.9K |
| Jun 17 | DYN Dyne Therapeutics, Inc. | Kerr Douglas | Insider | Sell | $16.3K |
| May 14 | DYN Dyne Therapeutics, Inc. | Kerr Douglas | Insider | Sell | $28.7K |
| Feb 17 | DYN Dyne Therapeutics, Inc. | Kerr Douglas | Insider | Grant | $2.1M |
| Dec 5 | DYN Dyne Therapeutics, Inc. | Kerr Douglas | Insider | Sell | $18.2K |
| Sep 8 | DYN Dyne Therapeutics, Inc. | Kerr Douglas | Insider | Sell | $58.8K |
| Jul 18 | DYN Dyne Therapeutics, Inc. | Kerr Douglas | Insider | Award | $607.5K |
8 filings